Daniel Lin, MD, comes from a family of educators and physicians. He went to college thinking he could do anything. “I quickly realized that biology and the study of cancer was my calling,” he said. His father is an academic pathologist whose calling was also cancer. “I grew up hearing about tumors. In eighth grade, I wanted a picture of a tumor for a report which I thought was really cool,” Dr. Lin said.
By the time Dr. Lin went to college, he knew his calling was medicine. He enjoys what he does and in particular, the education piece. He teaches residents and medical students, but it’s the teaching of his patients that he considers most important and is the most rewarding for him. “Educating a patient for his or her options for their cancer, about what to expect in the big picture, whether that’s about their surgery, or after surgery, or their general wellbeing later, I consider that to be an important part for their care,” he said. “The meaning of the word physician is teacher. I embrace that.”
Looking at prostate cancer in general, Dr. Lin knows the future lies in what can be achieved in research. Two areas of interest for him include treatment and understanding biomarkers of prostate cancer aggressiveness, and learning how to prevent prostate cancer. “Is there something we can measure in tissue, urine, or blood, that goes beyond what we already know about the patient to understand the behavior of prostate cancer?” Dr. Lin asked. “That can help recommend treatment or surveillance.” The other area of research interest for him is in prevention, avoiding prostate cancer to begin with, but preventing it from recurring as well. “What are you born with?” he asked. “Can we modulate your predisposition with diet or exercise? We know we are doing something to ourselves. Men in Asia particularly don’t really get much fatal prostate cancer, but when they start immigrating to this country, they start getting prostate cancer and more aggressive prostate cancers.” Many studies recognize that Japanese men are now getting more cancers similar to Caucasians.
Dr. Lin and his colleagues have done experiments with diet, specifically high-fat versus low-fat diets, over six weeks and biopsied prostates to see if they can see a difference. “The genes had favorable response to the diet,” Dr. Lin said. The question then moved to what to do with these patients and studies moved to specific foods and down to the enzyme level where Dr. Lin and colleagues now have a study with a broccoli enzyme in pill-form that they are studying in men.
Area of Clinical Practice
Genitourinary cancers, kidney cancer
I am a board certified urologist who specializes genitourinary oncologic surgery. I see patients at the Urology Clinic at UW Medical Center – Montlake.
My clinical and research interests include genitourinary oncology, early detection and prevention and basic research.
Vanderbilt University Medical Center
University of Washington, Dept. of Urology
Memorial Sloan-Kettering Cancer Center
Urology, 2003, 2013, American Board of Urology
Internship, University of Washington, Dept. of Surgery
Seattle Met's 2023 Top Doctors award
Dr. Lin has received this peer-nominated award for exceptional patient care for multiple years.
Seattle magazine's 2021 Top Doctors Award
Dr. Lin has been recognized as a Top Doctor in this peer-nominated award multiple years in a row.
At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes physicians, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like registered dietitians, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.